Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro

Neuroscience Letters

Volumn 248, Issue 1, 1998, Pages 61-64

  Fan, Dong Sheng ^a   Ogawa, Matsuo ^a   Ikeguchi, Kunihiko ^a   Fujimoto, Ken Ichi ^a   Urabe, Masashi ^a   Kume, Akihiro ^a   Nishizawa, Masatoyo ^a   Matsushita, Natsuki ^b,c   Kiuchi, Kazutoshi ^b   Ichinose, Hiroshi ^d   Nagatsu, Toshiharu ^d   Kurtzman, Gary J ^e   Nakano, Imaharu ^a   Ozawa, Keiya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e Avigen Inc   (United States)

Author keywords

Adeno associated virus vector; Dopaminergic neuron; Gene transfer; Glial cell line derived neurotrophic factor; Mesencephalic culture; Parkinson's disease

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; DOPAMINERGIC NERVE CELL; GENE TARGETING; MESENCEPHALON; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; CELLS, CULTURED; DEPENDOVIRUS; DOPAMINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MESENCEPHALON; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, WISTAR;

EID: 0032557516     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00313-9     Document Type: Article

References (29)

1. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
2. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J.-J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. 94:1997;8818-8823.
3. Choi-Lindberg D.L., Lin Q., Chang Y.-N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
4. Clarkson E.D., Zawada W.M., Freed C.R. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res. 289:1997;207-210.
5. Du B., Wu P., Boldt-Houle D.M., Terwilliger E.F. Efficient transduction of human neurons with an adeno-associated virus vector. Gene Ther. 3:1996;254-261.
6. During M.J., Naegele J.R., O'Malley K.L., Geller A.I. Long-term behavioral recovery in Parkinson's rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
7. Flotte T.R., Carter B.J. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:1995;357-362.
8. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt D.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
9. Gearhart D.A., Neafsey E.J., Collins M.A. Characterization of brain beta-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease. Neurochem. Res. 22:1997;113-121.
10. Jing S., Wen D., Yu Y., Hoist P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
11. Kamegai M., Niijima K., Kunishita T., Nishizawa M., Ogawa M., Araki M., Ueki A., Konishi Y., Tabira T. Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron. 2:1990;429-436.
12. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:1994;148-154.
13. Le Gal La Salle G., Robert J.J., Bernard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M., Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
14. Lin L.-F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
15. Mahalik T.J., Hahn W.E., Clayton G.H., Owens G.P. Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol. 129:1994;27-36.
16. Mandel R.J., Spratt S.K., Snyder R.O., Leff S.E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA. 94:1997;14083-14088.
17. Martinez A., Haavik J., Flatmark T., Arrondo J.L.R., Muga A. Conformational properties and stability of tyrosine hydroxylase studied by infrared spectroscopy. J. Biol. Chem. 271:1996;19737-19742.
18. Matsushita N., Fujita Y., Tanaka N., Nagatsu T., Kiuchi K. Cloning and structural organization of the gene encoding the mouse glial cell-line-derived neurotrophic factor. GDNF, Gene. 203:1997;149-157.
19. Mizuno, Y., Ikebe, S., Hattori, N., Mochizuki, H., Nishi, K., Yoshino, H. and Kondo, T., Pathogenesis of nigral cell death in Parkinson's disease. In I. Hanin, M. Yoshida and A. Fisher (Eds.), Alzheimer's and Parkinson's Disease, Plemun, New York, 1995, pp. 211-216.
20. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29:1997;99-111.
21. Nagatsu I., Kondo Y., Inagaki S., Kojima H., Nagatsu T. Immunofluorescent and biochemical studies on tyrosine hydroxylase and dopamine-beta-hydroxylase of the bullfrog sciatic nerves. Histochemistry. 61:1979;103-109.
22. Naveilhan P., Baudet C., Mikaels A., Shen L., Westphal H., Ernfors P. Expression and regulation of GFRa3, a glial cell line-derived neurotrophic factor family receptor. Proc. Natl. Acad. Sci. USA. 95:1998;1295-1300.
23. Ogawa M., Araki M., Niijima K., Naito M., Yoshida M. Microglial reactions in the inferior olive and its tract induced by intraperitoneal injection of 3-acetylpyridine in the rat. Neurodegeneration. 1:1992;37-43.
24. Ogawa, M., Ogura, K., Nagatsuka, Y., Ohta, S., Imai, I., Nagatsu, I., Nagatsu, T. and Yoshida, M., Effects of chronic administration of 1,2,3,4-tetrahydroisoquinoline and its derivatives on the monkey: immunohistochemical study. In: I. Hanin, M. Yoshida and A. Fisher (Eds.), Alzheimer's and Parkinson's Disease, Plemun, New York, 1995, pp. 583-587.
25. Sauer H., Rosenblad C., Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
26. Tomac A., Lindqvist E., Lin L.-F.H., Ogren S., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
27. Unsicker K. GDNF: a cytokine at the interface of TGF-β and neurotrophins. Cell Tissue Res. 286:1996;175-178.
28. Wang C.-Y., Ni J., Jiang H., Hsu T.-A., Dugich-Djordjevic M., Feng L., Zhang M., Mei L., Gentz R., Lu B. Cloning and characterization of glial cell line-derived neurotrophic factor-β: a novel receptor for members of glial cell line-derived neurotrophic factor family of neurotrophic factors. Neurosci. 83:1998;7-14.
29. Yoshida M., Niwa T., Nagatsu T. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes. Neurosci. Lett. 119:1990;109-113.